Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...
A study published in the journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take ...
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have comorbid type 2 diabetes, high body mass index, and a previous metformin ...
A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in ...
Ozempic could cut binge drinking and opioid abuse, major research suggests. A US study of more than 800,000 people with a ...
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...